PHARMACEUTICAL INDUSTRY M.MURAT GÜÇLÜ 224 MUHAMMED KILIÇ 9-B

INTRODUCTION Turkey is the 16th country among the world's 35 leading pharmaceutical producing countries. Turkey has the lowest pharmaceutical consumption rate.

Turkish pharmaceutical industry production is mostly realized: under licenses agreements, the industry has high added value, huge production and export capacity.

HISTORY OF PHARMACEUTICAL INDUSTRY Graph 1: World Pharmaceuticals Market 80% of the world pharmaceuticals production is generated by developed countries. s%20industry%20ppt&source=web&cd=18&ved=0CFsQFj AHOAo&url=http%3A%2F%2Fpharmacy.oregonstate.edu %2Fdrug_policy%2FPresentations%2FAG_Grant%2FMod ules%2FMarketing%2FMarketing_ ppt&ei=ZoOlTrfr EuSB4AS2oPzqBA&usg=AFQjCNEJE4PLUPQBQ67H7jQ 0BrAIyzfU0Q&sig2=u8jXB8jCyGtxN4P7i6Kkag

Turkish pharmaceutical industry Pharmaceutical industry has become one of the most progressive sectors in Turkey : Fabrication period International pharmaceutical companies : Bayer (Germany), Aventis Pharmaceuticals, Inc (US), Pfizer (US), Roche (Switzerland), Sanofi (France) and Novartis (Switzerland). The leading Turkish manufacturers are Eczacıbaşı, Abdi İbrahim, Fako, İlsan İltaş, İbrahim Ethem and Bilim. Medium level of concentration which is 33,41 CR4.

MARKETTING Market overview Turkey’s present population is at around 74 million The number of people per hospital bed is 380 There are 83,200 doctors, 77,000 nurses and 14,700 dentists The number of patients per doctor is 800 The population per dentist is 4,500 dustry&source=web&cd=4&ved=0CEcQFjAD&url=http%3A%2F% 2Fkisi.deu.edu.tr%2Fsedef.akgungor%2FPH.ppt&ei=e4ClToS4D Y68-QbQ_o2dBQ&usg=AFQjCNFFuoI-lIZ0gw9JPQnEf-IL5qz- AA&sig2=SlgtjAG3cePDi3Zjs8252w

Turkey’s annual per capita health expenditure is USD 160. Europe-wide per capita spending on health care goods and services is USD 2,140. There are 22,000 pharmacies in Turkey. There are about 900 pharmacists graduate from university each year. &source=web&cd=4&ved=0CEcQFjAD&url=http%3A%2F%2Fkisi.deu.e du.tr%2Fsedef.akgungor%2FPH.ppt&ei=e4ClToS4DY68- QbQ_o2dBQ&usg=AFQjCNFFuoI-lIZ0gw9JPQnEf-IL5qz- AA&sig2=SlgtjAG3cePDi3Zjs8252w

The Porter’s diamond concept in a pharmaceutical setting

Pharmaceutical production in Turkey YearsQuantity ,000, ,005,000, ,100,000, ,000, ,000,000

Raw Material Production Table 4 : Production of pharmaceutical raw materials in Turkey YearsQuantity , , , , ,909

The production of raw materials in Turkey concentrates on many active ingredients of pharmaceuticals, primarily antibiotics and analgesics, by using fermentation, extraction and synthesis methods. The Turkish pharmaceutical raw materials sector is represented by 11 plants of private sector and 1 plant of public sector. The major characteristics of pharmaceuticals raw materials industry are: the investments are made at a great proportion by privately owned companies, the existing production capacity can be easily shifted to various production possibilities.

Foreign Trade Exports: In 2003 total value of pharmaceutical industry exports reached US$ 220 million. Imports: Turkey's pharmaceutical industry imports have shown an increase by years and reached to US$ 2,296 million in Avr. yearly growth (%) Imports1,3001,5001,7001,95015 Local Production 9001,2001,4001,60017 Exports Total Market 2,0682,5602,9163,35015

Major export products are the ones containing Penicillin, -Penicillin, -Antibiotics, -Alkaloid medicaments. Turkey is now exporting various pharmaceutical products to 50 countries including developed countries like, Germany, the United States, Austria, Belgium, Finland, the Netherlands, the United Kingdom, Switzerland, Italy and Japan. EXPORTS industry-.html

IMPORTS finished formsIn our country the pharmaceuticals industry, as in all developed countries, is importing some products in finished forms. Major import products of the industry are medicaments consisting of mixed or unmixed products. Major countries from which pharmaceutical products imported are the United Kingdom, Germany, France, the United States, Switzerland and Italy.

Investments Graphs 2: Investments, 2001 ( US$ Millions ) The industry is continuously in loss due to unstable pricing policies

EOAAAAQAAJ&oi=fnd&pg=PR10&dq=what+is +pharmaceutical+industry&ots=yrgDpCCC11&s ig=SYIeA6lwP7pTI1qh34VAvus8e0c#v=onepag e&q=what%20is%20pharmaceutical%20industr y&f=false

THANK YOU FOR LISTENING TO US